Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080262 | SCV000112157 | benign | not specified | 2013-04-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080262 | SCV000309664 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000080262 | SCV000517086 | benign | not specified | 2016-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001527219 | SCV001738165 | benign | Miyoshi muscular dystrophy 1 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664341 | SCV001876195 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664340 | SCV001876196 | benign | Distal myopathy with anterior tibial onset | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055162 | SCV002328744 | benign | Qualitative or quantitative defects of dysferlin | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004709226 | SCV005240202 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000080262 | SCV001919649 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000080262 | SCV001955645 | benign | not specified | no assertion criteria provided | clinical testing |